The Enterprise Value as of September 2024 (TTM) for Mustang Bio, Inc. (MBIO) is 6.30M

According to Mustang Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.30M. This represents a change of -36.26% compared to the average of 9.88M of the last 4 quarters.

Mustang Bio, Inc. (MBIO) Historical Enterprise Value (quarterly & annually)

How has MBIO Enterprise Value performed in the past?

The mean historical Enterprise Value of Mustang Bio, Inc. over the last ten years is 101.06M. The current 6.30M Enterprise Value has changed 523.37% with respect to the historical average. Over the past ten years (40 quarters), MBIO's Enterprise Value was at its highest in in the December 2017 quarter at 4.51B. The Enterprise Value was at its lowest in in the June 2022 quarter at -11168947.40.

Mustang Bio, Inc. (MBIO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mustang Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mustang Bio, Inc. (MBIO) Average Enterprise Value

How has MBIO Enterprise Value performed in the past?

The current Enterprise Value of Mustang Bio, Inc. (MBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Mustang Bio, Inc. (MBIO) Enterprise Value vs. Peers

How is MBIO’s Enterprise Value compared to its peers?

Mustang Bio, Inc.’s Enterprise Value is less than Checkpoint Therapeutics, Inc. (100.97M), less than Reviva Pharmaceuticals Holdings, Inc. (33.64M), less than Fortress Biotech, Inc. (57.16M), less than Kodiak Sciences Inc. (97.54M), less than Fortress Biotech, Inc. (57.16M), greater than Achilles Therapeutics plc (-61656377.00), greater than Aptose Biosciences Inc. (-647435.00), less than Aditxt, Inc. (10.43M), greater than NeuroBo Pharmaceuticals, Inc. (2.36M), greater than Dermata Therapeutics, Inc. (-2157220.00), less than Unicycive Therapeutics, Inc. (40.54M), greater than Revelation Biosciences, Inc. (-10594336.00), less than Affimed N.V. (57.87M), less than Leap Therapeutics, Inc. (37.18M), less than Adaptimmune Therapeutics plc (116.69M), less than Corvus Pharmaceuticals, Inc. (357.31M), less than Akari Therapeutics, Plc (38.48M), greater than Salarius Pharmaceuticals, Inc. (-995790.00), greater than Axcella Health Inc. (-7493000.00), greater than Magenta Therapeutics, Inc. (-114170976.00), greater than Histogen Inc. (-3643892.00),

Build a custom stock screener for Mustang Bio, Inc. (MBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mustang Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mustang Bio, Inc. (MBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mustang Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.